Cyrille Drouot

Title: Cyrille Drouot: Innovator in Pharmaceutical Chemistry

Introduction

Cyrille Drouot is a notable inventor based in Draguignan, France. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel chemical compounds. With a total of 9 patents to his name, Drouot's work focuses on creating innovative solutions for medical applications.

Latest Patents

Drouot's latest patents include "Oxime derivatives of 3,5-seco-4-nor-cholestane, pharmaceutical compositions containing same, and method for preparing same." This invention relates to novel chemical compounds, specifically oxime derivatives of 3,5-seco-4-nor-cholestane, which are aimed at applications as drugs, particularly cytoprotective drugs. More specifically, these compounds are designed to serve as neuroprotective, cardioprotective, and hepatoprotective agents. Another significant patent is "Derivatives of 3.5-seco-4-norcholestane and use thereof," which details compounds that can be utilized as medicaments, particularly as neuroprotectors.

Career Highlights

Cyrille Drouot is currently associated with Trophos, a company that focuses on developing innovative therapies for neurological diseases. His work at Trophos has allowed him to explore the potential of his patented compounds in clinical settings, contributing to advancements in medical science.

Collaborations

Drouot has collaborated with notable colleagues such as Thierry Bordet and Bruno Buisson. These partnerships have facilitated the exchange of ideas and expertise, enhancing the development of his innovative pharmaceutical solutions.

Conclusion

Cyrille Drouot stands out as a prominent inventor in the pharmaceutical field, with a focus on developing compounds that offer significant medical benefits. His contributions through patents and collaborations continue to influence advancements in drug development.